bIn order to identify immunoreactive proteins that are usable for the immunological diagnosis of Babesia ovis infections, a phage lambda cDNA expression library was constructed and screened using parasite-specific immune serum. Immunoscreening resulted in the identification of a full-length cDNA clone encoding a secreted protein designated Babesia ovis secreted antigen 1 (BoSA1). The full-length BoSA1 cDNA contained a 1,137-bp open reading frame that encoded a protein of 378 amino acids, with a signal peptide and 2 internal repeat domains. The theoretical molecular mass of the mature protein was 42.5 kDa. Recombinant BoSA1 (rBoSA1) protein was expressed in Escherichia coli strain DH5␣ cells as a glutathione S-transferase (GST) fusion protein and was purified by affinity chromatography. Purified rBoSA1 was tested for reactivity with sera from animals experimentally or naturally infected with B. ovis, in an indirect enzyme-linked immunosorbent assay (ELISA). The results showed that specific antibodies against rBoSA1 were detectable on days 7 and 8 of the experimental infection and were maintained during the sampling period. Additionally, 38 field sera taken from sheep naturally infected with B. ovis gave strong positive reactions in the ELISA between day 20 and day 30 of treatment. As a result, the identified recombinant BoSA1 protein seems to be a promising diagnostic antigen that is usable for the development of serological assays for the diagnosis of ovine babesiosis. This is the first report on the molecular cloning, expression, and potential use of a recombinant antigen for the diagnosis of ovine babesiosis. O vine babesiosis, caused by the tick-borne intraerythrocytic apicomplexan parasite Babesia ovis, is an acute disease characterized by clinical signs such as fever, hemolytic anemia, hemoglobinuria, and icterus in small ruminants. The disease is endemic in European, African, Asian, and Far Eastern countries (1-8). Babesia ovis is highly pathogenic and, in serious infections, causes pancytopenia. Untreated cases usually result in the death of sick animals, and even some treated animals may die as a result of heavy infection. Many recurrences also occur after the treatment period. Compensation for the abnormalities in the hematological profiles of acutely infected animals takes a long time after the treatment period (8). Currently, control of ovine babesiosis is based only on chemotherapy and limited tick control measures. In areas in which the status of B. ovis endemicity is unstable, an immunization program is needed (9). However, immunoprophylaxis is lacking for Babesia species in sheep.Currently, the diagnosis of ovine babesiosis includes microscopic examination of Giemsa-stained thin blood smears. Although intraerythrocytic parasites are apparent in clinical cases, it is very difficult to detect the organisms by microscopy in chronic infections, because of the low levels of parasitemia (10-12). The analysis of blood smears usually depends on the experience of the observer. The morphological changes in ...